Vikeså Jonas, Møller Anne Kirstine H, Kaczkowski Bogumil, Borup Rehannah, Winther Ole, Henao Ricardo, Krogh Anders, Perell Katharina, Jensen Flemming, Daugaard Gedske, Nielsen Finn C
Center for Genomic Medicine, Rigshospitalet, University of Copenhagen, Blegdamsvej 9, DK-2100, Copenhagen Ø, Denmark.
Department of Oncology, University of Copenhagen, Blegdamsvej 9, DK-2100, Copenhagen Ø, Denmark.
BMC Cancer. 2015 Mar 19;15:151. doi: 10.1186/s12885-015-1128-x.
BACKGROUND: Cancers of unknown primary (CUPs) constitute ~5% of all cancers. The tumors have an aggressive biological and clinical behavior. The aim of the present study has been to uncover whether CUPs exhibit distinct molecular features compared to metastases of known origin. METHODS: Employing genome wide transcriptome analysis, Linear Discriminant Analysis (LDA) and Quadratic Discriminant Analysis (QDA), we defined the putative origins of a large series of CUP and how closely related a particular CUP was to corresponding metastases of known origin. LDA predictions were subsequently used to define a universal CUP core set of differentially expressed genes, that by means of gene set enrichment analysis was exploited to depict molecular pathways characterizing CUP. RESULTS: The analyses show that CUPs are distinct from metastases of known origin. CUPs exhibit inconsistent expression of conventional cancer biomarkers and QDA derived outlier scores show that CUPs are more distantly related to their primary tumor class than corresponding metastases of known origin. Gene set enrichment analysis showed that CUPs display increased expression of genes involved in DNA damage repair and mRNA signatures of chromosome instability (CIN), indicating that CUPs are chromosome unstable compared to metastases of known origin. CONCLUSIONS: CIN may account for the uncommon clinical presentation, chemoresistance and poor outcome in patients with CUP and warrant selective diagnostic strategies and treatment.
背景:原发灶不明的癌症(CUPs)约占所有癌症的5%。这些肿瘤具有侵袭性的生物学和临床行为。本研究的目的是揭示与已知原发灶转移瘤相比,CUPs是否表现出独特的分子特征。 方法:利用全基因组转录组分析、线性判别分析(LDA)和二次判别分析(QDA),我们确定了大量CUPs的假定起源,以及特定CUP与已知原发灶相应转移瘤的密切程度。随后,LDA预测被用于定义一个通用的CUP差异表达基因核心集,通过基因集富集分析来描绘表征CUP的分子途径。 结果:分析表明,CUPs与已知原发灶转移瘤不同。CUPs表现出传统癌症生物标志物的表达不一致,QDA衍生的异常值分数表明,与已知原发灶的相应转移瘤相比,CUPs与其原发肿瘤类别的关系更远。基因集富集分析表明,CUPs显示出参与DNA损伤修复的基因表达增加以及染色体不稳定(CIN)的mRNA特征,这表明与已知原发灶转移瘤相比,CUPs存在染色体不稳定。 结论:CIN可能是导致CUP患者临床表现不常见、化疗耐药和预后不良的原因,需要采取选择性的诊断策略和治疗方法。
Cancer Treat Rev. 2021-6
Oncologist. 2007-4
Case Rep Oncol. 2023-12-19
Front Artif Intell. 2021-4-13
Neuro Oncol. 2021-12-1
Cancers (Basel). 2021-1-25
EMBO Rep. 2012-6-1
J Transl Med. 2012-1-24
Nature. 2012-1-18
J Clin Oncol. 2011-4-20
Hum Mutat. 2010-11-9
Endocr Relat Cancer. 2010-7-28